#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12606	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2215	565.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1677	1677	T	657	T,C	596,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12606	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2215	565.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	793	C,T	734,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22920	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3564	641.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1674	1674	A	759	A	700	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22920	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3564	641.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2308	2308	C	727	C	682	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22920	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3564	641.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2382	2382	A	665	A	632	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22920	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3564	641.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2934	2934	C	709	C	655	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	89350	blaTEM	861	861	100.0	blaTEM.l6.c4.ctg.1	1693	4843.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1824	folP	855	855	99.88	folP.l15.c17.ctg.1	1384	130.2	1	SNP	p	R229S	1	.	.	685	687	AGC	987	989	AGC	197;195;195	A;G;C	183;181;182	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4724	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3515	134.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	717	719	GCC	147;149;148	G;C;C	132;134;131	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4724	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3515	134.1	1	SNP	p	S91F	1	.	.	271	273	TTC	705	707	TTC	157;157;157	T;T;C,A	140;141;140,1	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1488	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1346	110.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	448	450	ACC	178;178;175	A;C;C	164;163;161	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1488	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1346	110.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	646	648	CAC	184;183;183	C;A;C	179;175;178	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1488	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1346	110.4	0	.	p	.	0	A127fs	FSHIFT	379	379	G	712	712	G	188	G	169	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1488	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1346	110.4	1	SNP	p	G45D	0	.	.	133	135	GGC	466	468	GGC	172;176;175	G;G;C	156;161;160	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	786	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	906	85.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1475	1477	GTC	181;182;181	G;T;C	166;165;164	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	166;164;165	G;A;C	151;146;148	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	1	SNP	p	R87I	0	.	.	259	261	CGT	584	586	CGT	164;164;162	C;G;T	149;149;143	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	1	SNP	p	R87W	0	.	.	259	261	CGT	584	586	CGT	164;164;162	C;G;T	149;149;143	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	1	SNP	p	S87R	1	.	.	259	261	CGT	584	586	CGT	164;164;162	C;G;T	149;149;143	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4154	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2907	142.4	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	161;159;160	T;C;C	143;140;143	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3580	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2655	134.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1495	1497	GGC	171;169;170	G;G;C,T	155;150;149,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1236	1238	GCA	166;167;165	G;C;A	157;158;156	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1239	1241	ATC	164;165;166	A;T;C	155;154;156	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1251	1253	GTG	164;163;163	G;T;G	153;151;151	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1251	1253	GTG	164;163;163	G;T;G	153;151;151	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1755	1757	ACC	163;166;165	A;C;C	148;155;152	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1809	1811	GCG	160;159;156	G;C,G;G	142;126,1;137	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1809	1811	GCG	160;159;156	G;C,G;G	142;126,1;137	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1932	1934	GGT	160;158;157	G;G;T	143;142;141	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1941	1943	GGC	147;146;147	G;G;C	136;135;136	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3428	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2404	142.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1959	1961	CCG	142;142;143	C,G;C;G,C	108,1;113;111,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5018	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2959	168.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1566	1568	CCG	177;178;172	C;C;G	157;164;156	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1978	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1723	114.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	510	510	C	151	C	140	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	104	106	TTA	42;44;44	T;T;A	33;36;36	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	149	151	CAT	47;46;43	C;A;T	42;41;40	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	152	154	AGT	44;44;44	A;G;T	40;40;39	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	161	163	TAC	45;45;45	T;A;C	39;38;39	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	R307E	NONSYN	919	921	AGA	251	253	GAA	11;10;11	G;A;A	10;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	263	265	GCA	10;11;11	G;C;A	10;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	272	274	ATC	11;11;11	A;T;C	10;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	278	280	TCG	11;11;11	T;C;G	10;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	284	286	GCC	9;9;9	G;C;C	8;9;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	287	289	AGC	10;10;10	A;G;C	10;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	290	292	GCC	10;10;10	G;C;C	9;8;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	256	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	386	24.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	296	298	GTT	10;10;10	G;T;T	10;10;10	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	701	703	GGA	204;203;203	G;G;A	188;186;184	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	0	.	p	.	0	.	INDELS	629	630	AA	904	906	TAG	181;177;173	T;A;G	168;165;160	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	908	911	CAAT	173;170;167;165	C;A;A;T	161;159;154;151	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	913	913	T	170	T	158	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	1	SNP	p	G120K	0	.	.	358	360	GGT	632	634	GGT	216;212;213	G;G;T	198;197;195	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	1	SNP	p	A121N	0	.	.	361	363	GCC	635	637	GCC	209;208;207	G,A;C;C	194,1;190;191	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2368	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1460	160.1	1	SNP	p	A121D	0	.	.	361	363	GCC	635	637	GCC	209;208;207	G,A;C;C	194,1;190;191	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9152	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4812	189.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2028	2030	AAT	185;187;187	A;A;T	178;181;180	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	990	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	934	105.0	1	SNP	p	V57M	1	.	.	169	171	ATG	535	537	ATG	207;208;205	A;T;G	191;194;192	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	M177T	NONSYN	529	531	ATG	893	895	ACG	372;370;370	A,G;C;G	354,1;357;355	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	914	916	GAC	308;302;305	G,A;A;C	304,1;299;303	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	T190M	NONSYN	568	570	ACG	932	934	ATG	287;285;284	A;T;G,T	285;284;281,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	L194S	NONSYN	580	582	TTA	944	946	TCA	289;287;288	T;C;A	287;284;284	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	989	991	CAG	282;281;276	C;A;G	277;277;272	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1010	1012	CTT	288;293;296	C;T;T	284;288;292	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1031	1033	AGT	318;322;328	A;G;T	312;314;315	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1100	1102	CCG	495;495;501	C;C;G	451;453;457	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1202	1204	TCG	469;472;473	T;C;G	436;440;438	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1373	1375	AAA	296;295;287	A;A;A	277;279;272	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1376	1378	AAG	283;279;274	A;A;G	267;267;256	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1391	1393	CAC	231;233;235	C;A;C	227;224;233	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1430	1432	GAA	215;216;219	G;A;A	213;216;219	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1508	1510	ACG	146;145;145	A;C;G,A	146;144;144,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1559	1561	ATT	232;233;235	A;T;T	221;221;222	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1562	1564	AGT	237;238;237	A;G;T	225;225;224	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1601	1603	CTA	273;271;278	C;T;A	244;243;249	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1643	1645	AAT	176;179;182	A;A;T	168;171;172	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1712	1714	TCA	248;248;247	T;C;A	241;240;238	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1736	1738	ATG	278;276;279	A;T;G	271;270;270	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2030	2032	ACC	528;528;534	A;C;C	484;488;494	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9930	tetM	1920	1920	96.3	tetM.l6.c4.ctg.1	2576	384.3	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2126	2128	GAA	574;573;570	G,A;A;A	536,1;537;532	.	Tetracycline resistance
